Genmab Q3 EPS $5.51 Beats $3.59 Estimate, Sales $1.187B Miss $1.194B Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings BeatsEarnings Misses
Genmab (NASDAQ:GMAB) reported quarterly earnings of $5.51 per share which beat the analyst consensus estimate of $3.59 by 53.48 percent. This is a 14.71 percent decrease over earnings of $6.46 per share from the same
Genmab (NASDAQ:GMAB) reported quarterly earnings of $5.51 per share which beat the analyst consensus estimate of $3.59 by 53.48 percent. This is a 14.71 percent decrease over earnings of $6.46 per share from the same period last year. The company reported quarterly sales of $1.187 billion which missed the analyst consensus estimate of $1.194 billion by 0.56 percent. This is a 16.14 percent increase over sales of $1.022 billion the same period last year.